Intravenous immunoglobulin therapy in immunoglobulin A vasculitis with gastrointestinal tract involvement

[1]  O. Karadag,et al.  Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease? , 2022, Internal and Emergency Medicine.

[2]  G. Indolfi,et al.  Gastrointestinal involvement in IgA vasculitis: a single-center 11-year study on a cohort of 118 children , 2021, Clinical Rheumatology.

[3]  M. Gattorno,et al.  Intravenous immunoglobulin for corticosteroid-resistant intestinal Henoch-Schönlein purpura: worth a controlled trial against corticosteroids? , 2020, Rheumatology.

[4]  C. Inderjeeth,et al.  Long-Term Risk of Comorbidity after IgA Vasculitis in Childhood: A Population-Based Cohort Study , 2020, Rheumatology and Therapy.

[5]  M. Yılmaz,et al.  Do practical laboratory indices predict the outcomes of children with Henoch-Schönlein purpura? , 2019, Postgraduate medicine.

[6]  E. Çakıcı,et al.  MEFV gene mutations in children with Henoch–Schönlein purpura and their correlations—do mutations matter? , 2019, Clinical Rheumatology.

[7]  B. Cherqaoui,et al.  Intravenous immunoglobulins for severe gastrointestinal involvement in pediatric Henoch-Schönlein purpura: A French retrospective study. , 2016, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[8]  D. Karabel,et al.  Management of intestinal bleeding with single‐dose cyclophosphamide in Henoch–Schönlein purpura , 2015, Pediatrics international : official journal of the Japan Pediatric Society.

[9]  K. Srinivasan,et al.  Gastrointestinal manifestations of Henoch-Schonlein purpura: A report of two cases. , 2015, World journal of radiology.

[10]  I. Bruce,et al.  Indications for IVIG in rheumatic diseases. , 2015, Rheumatology.

[11]  J. Chen,et al.  Association of the paired box 2 gene polymorphism with the susceptibility and pathogenesis of Henoch‑Schönlein purpura in children. , 2015, Molecular medicine reports.

[12]  Ayesha Fatima,et al.  Pneumatosis Intestinalis Associated With Henoch–Schönlein Purpura , 2014, Pediatrics.

[13]  P. Trnka.  Henoch–Schönlein purpura in children , 2013, Journal of paediatrics and child health.

[14]  J. Jennette.  Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides , 2013, Clinical and Experimental Nephrology.

[15]  E. McDermott,et al.  The role of high-dose intravenous immunoglobulin in rheumatology. , 2010, Rheumatology.

[16]  S. Gunturu,et al.  Henoch-Schonlein Purpura—A Case Report and Review of the Literature , 2010, Gastroenterology research and practice.

[17]  M. Biburger,et al.  Mechanisms of action of intravenous immunoglobulins , 2010, Expert review of clinical immunology.

[18]  M. Duman,et al.  Mean platelet volume in Henoch-Schönlein purpura: relationship to gastrointestinal bleeding , 2009, Clinical Rheumatology.

[19]  J. Hooper.  Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations , 2008, Immunology and Allergy Clinics of North America.

[20]  S. Kaveri,et al.  Role of natural antibodies in immune homeostasis: IVIg perspective. , 2008, Autoimmunity reviews.

[21]  E. Ito,et al.  Leukocytapheresis for the treatment of refractory Henoch–Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy , 2008, Rheumatology International.

[22]  M. Thomson,et al.  Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion , 2007, European Journal of Pediatrics.

[23]  Jae Hun Chung,et al.  Acute Appendicitis in Henoch-Schönlein Purpura : A Case Report , 2005, Journal of Korean medical science.

[24]  S. Mrusek,et al.  Henoch-Schönlein purpura , 2004, The Lancet.

[25]  Y. Naparstek,et al.  Henoch Schonlein purpura in children and adults: is it one entity? , 2002, Seminars in arthritis and rheumatism.

[26]  B. Dupas,et al.  Intravenous immunoglobulin in Henoch-Schönlein purpura. , 1996, Annals of Internal Medicine.

[27]  J. Sany.  Intravenous immunoglobulin therapy for rheumatic diseases , 1994, Current Opinion in Rheumatology.

[28]  P. Bierling,et al.  High-Dose Immunoglobulin Therapy for Severe IgA Nephropathy and Henoch-Schonlein Purpura , 1994, Annals of Internal Medicine.